A method to detect the earliest stages of inhalation anthrax infection will soon undergo a clinical trial to assess its efficacy.
As reported in the December issue of The Journal of Nuclear Medicine, researchers at Walter Reed Army Medical Center in Washington will assess the efficacy of a technetium Tc 99m–labeled monoclonal antibody for imaging early-stage inhalation anthrax infection. The technique promises to detect the earliest stages of infection before any other laboratory or radiographic diagnostic test and well before serious symptoms of the infection are apparent.
Mitka M. Early Anthrax Identification. JAMA. 2002;287(4):443. doi:10.1001/jama.287.4.443